Titan Pharmaceuticals Reports Positive Results From Phase 3 Study of Probuphine for Opioid Addiction June 8, 2015
Titan Pharmaceuticals Schedules Conference Call to Review Results From Phase 3 Study of Probuphine for Opioid Addiction June 5, 2015
Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2015 Financial Results May 8, 2015
Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2014 Financial Results March 25, 2015
Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for Opioid Dependence November 20, 2014
